PD-L1 expression in liver metastasis: its clinical significance and discordance with primary tumor in colorectal cancer

BACKGROUND: The outcomes of immune checkpoint inhibitors in cancer patients with liver metastases are poor, which may be related to a different tumor microenvironment in liver metastases from primary tumors. This study was aimed to analyze PD-L1 expression and the immune microenvironment status in l...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xiao-Li, Luo, Xuan, Sheng, Hui, Wang, Yun, Chen, Dong-Liang, Li, Jia-Ning, Wang, Feng-Hua, Xu, Rui-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730753/
https://www.ncbi.nlm.nih.gov/pubmed/33308232
http://dx.doi.org/10.1186/s12967-020-02636-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730753/
https://www.ncbi.nlm.nih.gov/pubmed/33308232
http://dx.doi.org/10.1186/s12967-020-02636-x

Ejemplares similares